title: Omalizumab use during pregnancy for chronic spontaneous urticaria (CSU): report of two cases.
authors.affiliation: Allergy Section, Vall d'Hebron Hospital, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: González-Medina
authors.affiliation: Dermatology Department, Hospital del Mar, Universitat Autònoma de Barcelona, Passeig Marítim, 25-29, 08003, Barcelona, Spain.
authors.forename: L
authors.initials: L
authors.lastname: Curto-Barredo
authors.affiliation: Allergy Section, Vall d'Hebron Hospital, Universitat Autònoma de Barcelona, Passeig Vall d'Hebron 119-129, 08035, Barcelona, Spain.
authors.forename: M
authors.initials: M
authors.lastname: Labrador-Horrillo
authors.affiliation: Dermatology Department, Hospital del Mar, Universitat Autònoma de Barcelona, Passeig Marítim, 25-29, 08003, Barcelona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Giménez-Arnau
mesh_terms: D000328:Adult; D018926:Anti-Allergic Agents / Q000627:therapeutic use; D002908:Chronic Disease; D005260:Female; D006801:Humans; D000069444:Omalizumab / Q000627:therapeutic use*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy*; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D018926:Anti-Allergic Agents; D000069444:Omalizumab